164 related articles for article (PubMed ID: 28558956)
1. Association between plasma BMP-2 and in-stent restenosis in patients with coronary artery disease.
Zheng WP; Yang M; Su LX; Ning Y; Wen WW; Xin MK; Zhao X; Zhang M
Clin Chim Acta; 2017 Aug; 471():150-153. PubMed ID: 28558956
[TBL] [Abstract][Full Text] [Related]
2. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease.
Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Akyel A; Mendi MA; Oksuz F
Platelets; 2015; 26(1):48-52. PubMed ID: 24831828
[TBL] [Abstract][Full Text] [Related]
3. The value of serum visfatin in predicting in-stent restenosis of drug-eluting stents.
Wu XA; Xie G; Li XQ; Wu HT; Wang X
Clin Chim Acta; 2018 Apr; 479():20-24. PubMed ID: 29305846
[TBL] [Abstract][Full Text] [Related]
4. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
5. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
Chen T; Sun JL; Zhang J
Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235
[TBL] [Abstract][Full Text] [Related]
6. The Relationship Between Lymphocyte-to-Monocyte Ratio and Bare-Metal Stent In-Stent Restenosis in Patients With Stable Coronary Artery Disease.
Murat SN; Yarlioglues M; Celik IE; Kurtul A; Duran M; Kilic A; Oksuz F
Clin Appl Thromb Hemost; 2017 Apr; 23(3):235-240. PubMed ID: 26759373
[TBL] [Abstract][Full Text] [Related]
7. Levels of plasma Quaking and cyclooxygenase-2 predict in-stent restenosis in patients with coronary artery disease after percutaneous coronary intervention.
Wang P; Kuang Y; Liu Y; Zhang Y; Gao H; Ma Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):739-747. PubMed ID: 35837773
[TBL] [Abstract][Full Text] [Related]
8. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
[TBL] [Abstract][Full Text] [Related]
9. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
10. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
Tesche C; De Cecco CN; Vliegenthart R; Duguay TM; Stubenrauch AC; Rosenberg RD; Varga-Szemes A; Bayer RR; Yang J; Ebersberger U; Baquet M; Jochheim D; Hoffmann E; Steinberg DH; Chiaramida SA; Schoepf UJ
J Cardiovasc Comput Tomogr; 2016; 10(5):377-83. PubMed ID: 27431607
[TBL] [Abstract][Full Text] [Related]
11. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
[TBL] [Abstract][Full Text] [Related]
12. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.
Kang SJ; Cho YR; Park GM; Ahn JM; Han SB; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1183-90. PubMed ID: 24229771
[TBL] [Abstract][Full Text] [Related]
13. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.
Wang P; Qiao H; Wang R; Hou R; Guo J
BMC Cardiovasc Disord; 2020 Dec; 20(1):510. PubMed ID: 33276720
[TBL] [Abstract][Full Text] [Related]
14. Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up.
Cheng G; Chang FJ; Wang Y; You PH; Chen HC; Han WQ; Wang JW; Zhong NE; Min ZQ
Med Sci Monit; 2019 Jan; 25():240-247. PubMed ID: 30617247
[TBL] [Abstract][Full Text] [Related]
15. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Yıldırım E; Çelik M; Yüksel UÇ; Buğan B; Gökoğlan Y; Görmel S; Yaşar S; Koklu M; İyisoy A; Barçın C
Turk Kardiyol Dern Ars; 2017 Dec; 45(8):702-708. PubMed ID: 29226890
[TBL] [Abstract][Full Text] [Related]
17. CHA
Zhao SG; Xu JJ; Tao ZH; Jin L; Liu Q; Zheng WY; Jiang LQ; Wang NF
J Int Med Res; 2019 Jun; 47(6):2533-2544. PubMed ID: 31039653
[TBL] [Abstract][Full Text] [Related]
18. Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease.
Yoshimura M; Umemoto S; Kawano R; Hiromoto M; Yamada M; Fujimura T; Tanaka M; Nao T; Miura T; Yano M
Int Heart J; 2021; 62(5):970-979. PubMed ID: 34588411
[TBL] [Abstract][Full Text] [Related]
19. Changes of plasma Rap1A levels in patients with in-stent restenosis after percutaneous coronary intervention and the underlying mechanisms.
Gao H; Kuang Y; Liu Y; Zhang Y; Wang P; Ma Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1650-1658. PubMed ID: 38432855
[TBL] [Abstract][Full Text] [Related]
20. Remnant Lipoprotein Cholesterol Independently Associates With In-Stent Restenosis After Drug-Eluting Stenting for Coronary Artery Disease.
Xu X; Pandit RU; Han L; Li Y; Guo X
Angiology; 2019 Oct; 70(9):853-859. PubMed ID: 31167539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]